|
273
|
949
|
4gb9A |
Potent and highly selective benzimidazole inhibitors of pi3k-delta |
|
118
|
327
|
4grbA |
Casein kinase 2 (ck2) bound to inhibitor |
|
0
|
14
|
4gz3B |
Crystal structure of human o-glcnac transferase with udp and a thioglycopeptide |
|
100
|
329
|
4gubA |
Casein kinase ii bound to inhibitor |
|
82
|
273
|
4gw8A |
Human proto-oncogene serine threonine kinase (pim1) in complex with a consensus peptide and leucettine l41 |
|
0
|
14
|
4gyyB |
Crystal structure of human o-glcnac transferase with udp-5sglcnac and a peptide substrate |
|
83
|
299
|
4gueA |
Structure of n-terminal kinase domain of rsk2 with flavonoid glycoside quercitrin |
|
105
|
335
|
4gv1A |
Pkb alpha in complex with azd5363 |
|
0
|
14
|
4gywB |
Crystal structure of human o-glcnac transferase in complex with udp and a glycopeptide |
|
0
|
7
|
4ggdC |
Structural analysis of human cdc20 supports multisite degron recognition by apc/c. |
|
64
|
276
|
4g9cA |
Human b-raf kinase domain bound to a type ii pyrazolopyridine inhibitor |
|
26
|
66
|
4gehB |
Crystal structure of mst4 dimerization domain complex with pdcd10 |
|
77
|
278
|
4gh2A |
Crystal structure of the chk1 |
|
284
|
948
|
4fulA |
Pi3 kinase gamma bound to a pyrmidine inhibitor |
|
77
|
274
|
4g9rA |
B-raf v600e kinase domain bound to a type ii dihydroquinazoline inhibitor |
|
10
|
77
|
4g3xB |
Crystal structure of q61l h-ras-gppnhp bound to the rbd of raf kinase |
|
277
|
948
|
4flhA |
Crystal structure of human pi3k-gamma in complex with amg511 |
|
233
|
946
|
4g11A |
X-ray structure of pi3k-gamma bound to a 4-(morpholin-4-yl)- (6-oxo-1,6-dihydropyrimidin-2-yl)amide inhibitor |
|
83
|
278
|
4ft7A |
Crystal structure of the chk1 |
|
80
|
279
|
4ftcA |
Crystal structure of the chk1 |
|
81
|
278
|
4fswA |
Crystal structure of the chk1 |
|
80
|
268
|
4fstA |
Crystal structure of the chk1 |
|
82
|
269
|
4ftrA |
Crystal structure of the chk1 |
|
83
|
279
|
4ft9A |
Crystal structure of the chk1 |
|
85
|
285
|
4g34A |
Crystal structure of gsk6924 bound to perk (r587-r1092, delete a660-t867) at 2.70 a resolution |
|
107
|
360
|
4fr4A |
Crystal structure of human serine/threonine-protein kinase 32a (yank1) |
|
96
|
302
|
4g16A |
Crystal structure of ck1g3 with 2-[(4-{[3-(trifluoromethyl)pyridin2-yl]oxy}phenyl)amino]-1h-benzimidazole-6-carbonitrile |
|
83
|
278
|
4ftuA |
Crystal structure of the chk1 |
|
82
|
278
|
4ftaA |
Crystal structure of the chk1 |
|
79
|
277
|
4ftiA |
Crystal structure of the chk1 |
|
78
|
278
|
4ftmA |
Crystal structure of the chk1 |
|
81
|
278
|
4fsyA |
Crystal structure of the chk1 |
|
78
|
268
|
4fsuA |
Crystal structure of the chk1 |
|
81
|
286
|
4g31A |
Crystal structure of gsk6414 bound to perk (r587-r1092, delete a660-t867) at 2.28 a resolution |
|
16
|
78
|
4g0nB |
Crystal structure of wt h-ras-gppnhp bound to the rbd of raf kinase |
|
81
|
278
|
4ft5A |
Crystal structure of the chk1 |
|
81
|
277
|
4ftjA |
Crystal structure of the chk1 |
|
78
|
278
|
4fsrA |
Crystal structure of the chk1 |
|
83
|
278
|
4fsnA |
Crystal structure of the chk1 |
|
276
|
948
|
4fhjA |
Crystal structure of pi3k-gamma in complex with imidazopyridine 2 |
|
254
|
942
|
4fjzA |
Crystal structure of pi3k-gamma in complex with pyrrolo-pyridine inhibitor 63 |
|
78
|
278
|
4ftkA |
Crystal structure of the chk1 |
|
82
|
278
|
4ft0A |
Crystal structure of the chk1 |
|
93
|
302
|
4g17A |
Crystal structure of ck1g3 with 2-[(4-tert-butylphenyl)amino]-1h-benzimidazole-6-carbonitrile |
|
77
|
281
|
4fzfB |
Crystal structure of mst4-mo25 complex with dki |
|
80
|
269
|
4ftnA |
Crystal structure of the chk1 |
|
83
|
278
|
4fttA |
Crystal structure of the chk1 |
|
80
|
278
|
4fsmA |
Crystal structure of the chk1 |
|
80
|
281
|
4fzdB |
Crystal structure of mst4-mo25 complex with wsf motif |
|
79
|
268
|
4ftqA |
Crystal structure of the chk1 |
